Wedge Capital Management L L P NC decreased its position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 26.0% ...

Representative Josh Gottheimer (D-New Jersey) recently sold shares of Eli Lilly and Company (NYSE:LLY). In a filing disclosed ...

Humalog + Insulin Lispro have maintained a dominant ... in this case calculated on the basis of the last 12 months. Eli Lilly is an outstanding company, but the market may have overestimated ...

The company’s main products include Humalog, Trulicity ... transfer to locally manufacture the insulin. This initiative is part of Eli Lilly’s 30×30 goal, aimed at enhancing healthcare ...

Financial writer cautious on Eli Lilly stock despite strong performance, citing high valuation and underperforming drugs.

Eli Lilly has responded to criticism of high prices for insulin products in the US by launching a cut-price version of its Humalog brand ... to change,” says the company’s CEO David Ricks.

The company’s main products include Humalog, Trulicity ... transfer to locally manufacture the insulin. This initiative is part of Eli Lilly’s 30×30 goal, aimed at enhancing healthcare ...

Indianapolis-based drugmaker Eli Lilly and Company has announced price reductions ... effective as of Q4 2023. Both Humalog and Insulin Lispro Injection are fast-acting insulins, they are used ...

Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology. Having examined the options trading patterns of Eli Lilly, our attention now turns directly to the company.